Verastem Oncology
VSTM
#7097
Rank
C$0.55 B
Marketcap
$10.85
Share price
4.41%
Change (1 day)
-14.95%
Change (1 year)

Earnings for Verastem Oncology (VSTM)

Earnings in 2024 (TTM): -C$0.19 Billion

According to Verastem Oncology 's latest financial reports the company's current earnings are C$10 Million. a decrease over its 2023 earnings that were of -C$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verastem Oncology from 2011 to 2024

Annual earnings

Year Earnings Change
2024 -C$0.19 Billion49.31%
2023 -C$0.13 Billion18.36%
2022 -C$0.11 Billion3.67%
2021 -C$98.67 Million5.43%
2020 -C$93.59 Million-54.74%
2019 -C$0.21 Billion105.99%
2018 -C$0.11 Billion6.83%
2017 -C$93.96 Million86.06%
2016 -C$50.5 Million-37.03%
2015 -C$80.19 Million8.43%
2014 -C$73.96 Million29.52%
2013 -C$57.1 Million28.6%
2012 -C$44.4 Million133.9%
2011 -C$18.99 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$59.28 Million-67.21%๐Ÿ‡บ๐Ÿ‡ธ USA
C$15.40 B-8,618.84%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.61 B-995.20%๐Ÿ‡บ๐Ÿ‡ธ USA
C$6.08 B-3,468.70%๐Ÿ‡ฌ๐Ÿ‡ง UK